Skip to content
Dr. Richard H. Mann
Doctor of Podiatric Medicine
  • Home
  • About Dr. Mann
  • About Peripheral Neuropathy
    • Diabetic Neuropathy
    • Alcoholic Neuropathy
    • Neuropathy from Chemotherapy
    • Neuropathy of Unknown Cause (Idiopathic)
  • About Realm Labs
  • Schedule an Appointment
  • Clinical Updates**

Month: May 2020

COVID-19 and Guillain–Barré Syndrome

May 4, 2020 Dr. Mann Leave a comment

On April 17, 2020, the online New England Journal of Medicine published the correspondence Guillain-Barré Syndrome Associated with SARS-CoV-2.  The…

Continue Reading →

Posted in: Blog, Clinical Update

Looking for something?

Recent Posts

  • Polyneuropathy, Alzheimer’s Disease and Benfotiamine: Neurodegeneration and Vitamin B1 Deficiency
  • NIH Awards $45 Million to Fund Study on Benfotiamine and Alzheimer’s Disease
  • How Many People in the U.S. Have Peripheral Neuropathy?
  • A Common-Sense Approach for the Nutritional Treatment of Peripheral Neuropathy 
  • Alcohol Consumption and Diabetic Peripheral Neuropathy

Archives

  • October 2022 (1)
  • July 2022 (2)
  • March 2022 (1)
  • December 2021 (2)
  • October 2021 (1)
  • July 2021 (1)
  • May 2021 (1)
  • March 2021 (3)
  • May 2020 (1)
  • March 2020 (1)
  • December 2019 (1)
  • September 2019 (1)
  • August 2019 (1)
  • July 2019 (1)
  • June 2019 (1)
  • May 2019 (1)
  • April 2019 (2)
  • March 2019 (1)
  • January 2019 (2)
  • December 2018 (1)

Contact Us

  • Email
    rhmanndpmpa@gmail.com
  • Phone
    (561) 276-0900
  • Address
    13489 S. Military Trail
    Delray Beach, FL 33484

FDA Disclaimer

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Disclaimer

**The content herein is not to be considered medical advice.  It does not establish a doctor/patient relationship in any form between the reader, Dr. Mann, and/or anyone associated with Realm Labs.

Copyright © 2022 Dr. Richard H. Mann